As of 2024-12-12, the Fair Value of Urogen Pharma Ltd (URGN) is -13.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.44 USD, the upside of Urogen Pharma Ltd is -219.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -105.15 | -128.48 | -110.82 | -109.78 | -102.24 | -111.29 |
| YoY growth | -38.98% | -22.19% | 13.75% | 0.94% | 6.86% | -7.92% |
| Market Cap (mil) | 482.77 |
| P/E | |
| Forward P/E |
| EPS | -2.73 |
| Avg earnings growth rate | -7.92% |
| TTM earnings | -115.38 |